Bio-Techne

History

Year	Detail
1976	Bio-Techne was founded.
1978	The first R&D Systems product is released.
1981	The first 8-parameter blood control is developed at R&D Systems.
1984	Bio-Techne acquires General Diagnostics WBC products.
1988	Bio-Techne releases its first recombinant proteins.
1991	The company purchases Amgen’s research reagent and diagnostic assay kit business.
1993	R&D Systems Europe, Ltd. is established in the U.K.
1995	R&D Systems GmbH is established in Germany.
1998	Bio-Techne acquires Genzyme Corp.’s research products business.
2005	Bio-Techne acquires Fortron Bio Science Inc.
2007	R&D Systems China Co. Ltd. is established in Shanghai, China.
2011	Bio-Techne acquires Boston Biochem Inc.
2018	Bio-Techne acquires EuroCell Diagnostics.
2021	Bio-Techne completes the acquisition of Asuragen Inc.
2023	Bio-Techne completes the Lunaphore acquisition.

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI: Your Say